XML 52 R35.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Revenue (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Revenue from Contract with Customer [Abstract] |
Schedule of Disaggregation of Revenue | The Company’s revenue by product line, and related approximate percentage of total sales for 2024, 2023 and 2022 were as follows:
| Twelve Months Ended December 31, 2024 and 2023
| 2024 |  | 2023 |  | 2022
Nylon | $ | 348,501 |  |  | 23% |  | $ | 356,632 |  |  | 23% |  | $ | 485,241 |  |  | 25%
Caprolactam | 276,303 |  |  | 18% |  | 298,375 |  |  | 20% |  | 319,863 |  |  | 16%
Plant Nutrients* | 458,152 |  |  | 30% |  | 477,929 |  |  | 31% |  | 657,984 |  |  | 34%
Chemical Intermediates* | 434,601 |  |  | 29% |  | 400,663 |  |  | 26% |  | 482,552 |  |  | 25%
| $ | 1,517,557 |  |  | 100% |  | $ | 1,533,599 |  |  | 100% |  | $ | 1,945,640 |  |  | 100%
* The Company transferred certain products between its Chemical Intermediates product line and its Plant Nutrients product line to align more closely with its current sales structure. Historical information has been reclassified to reflect these changes for all periods presented in the Consolidated Financial Statements. Total revenue amounts were not impacted for either period. The Company’s revenues by geographic area, and related approximate percentage of total sales for 2024, 2023 and 2022 were as follows:
| Twelve Months Ended December 31, 2024 and 2023
| 2024 |  | 2023 |  | 2022
United States | $ | 1,304,971 |  |  | 86 | % |  | $ | 1,250,094 |  |  | 82 | % |  | $ | 1,622,537 |  |  | 83 | %
International | 212,586 |  |  | 14 | % |  | 283,505 |  |  | 18 | % |  | 323,103 |  |  | 17 | %
Total | $ | 1,517,557 |  |  | 100 | % |  | $ | 1,533,599 |  |  | 100 | % |  | $ | 1,945,640 |  |  | 100 | %
Schedule of Deferred Income and Customer Advances | Below is a roll-forward of Deferred income and customer advances for the twelve months ended December 31, 2024:
Deferred Income and Customer Advances |  |  | 2024
Opening balance January 1, 2024 |  |  | $ | 15,678 |
Additional cash advances |  |  | 37,954 |
Less amounts recognized in revenues |  |  | (16,094) |
Ending balance December 31, 2024 |  |  | $ | 37,538 |

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration